A detailed history of Wilbanks Smith & Thomas Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Wilbanks Smith & Thomas Asset Management LLC holds 13,234 shares of AMGN stock, worth $3.49 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
13,234
Previous 13,715 3.51%
Holding current value
$3.49 Million
Previous $3.95 Million 4.76%
% of portfolio
0.11%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$268.87 - $324.56 $129,326 - $156,113
-481 Reduced 3.51%
13,234 $3.76 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $918,474 - $1.04 Million
-3,592 Reduced 20.75%
13,715 $3.95 Million
Q3 2023

Nov 06, 2023

SELL
$218.65 - $271.46 $202,469 - $251,371
-926 Reduced 5.08%
17,307 $4.65 Million
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $40,925 - $48,393
-191 Reduced 1.04%
18,233 $4.05 Million
Q1 2023

May 05, 2023

BUY
$225.79 - $275.2 $1.75 Million - $2.13 Million
7,753 Added 72.65%
18,424 $4.45 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $60,692 - $77,117
265 Added 2.55%
10,671 $2.8 Million
Q3 2022

Oct 31, 2022

SELL
$224.46 - $253.15 $42,647 - $48,098
-190 Reduced 1.79%
10,406 $2.35 Million
Q2 2022

Aug 03, 2022

BUY
$230.71 - $256.74 $16,611 - $18,485
72 Added 0.68%
10,596 $2.58 Million
Q1 2022

May 05, 2022

BUY
$219.27 - $242.57 $44,292 - $48,999
202 Added 1.96%
10,524 $2.44 Million
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $28,240 - $32,319
-142 Reduced 1.36%
10,322 $2.32 Million
Q3 2021

Nov 04, 2021

SELL
$212.27 - $248.7 $9,976 - $11,688
-47 Reduced 0.45%
10,464 $2.23 Million
Q2 2021

Aug 04, 2021

SELL
$233.58 - $259.14 $48,351 - $53,641
-207 Reduced 1.93%
10,511 $2.56 Million
Q1 2021

May 11, 2021

SELL
$221.91 - $258.6 $26,629 - $31,032
-120 Reduced 1.11%
10,718 $2.67 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $13,631 - $16,233
63 Added 0.58%
10,838 $2.49 Million
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $15,721 - $17,483
67 Added 0.63%
10,775 $2.74 Million
Q2 2020

Jul 31, 2020

BUY
$197.81 - $242.74 $120,664 - $148,071
610 Added 6.04%
10,708 $2.53 Million
Q1 2020

May 06, 2020

BUY
$182.24 - $241.7 $659,526 - $874,712
3,619 Added 55.86%
10,098 $2.05 Million
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $87,793 - $112,844
464 Added 7.71%
6,479 $1.56 Million
Q3 2019

Nov 06, 2019

BUY
$174.11 - $208.62 $43,179 - $51,737
248 Added 4.3%
6,015 $1.16 Million
Q2 2019

Aug 07, 2019

SELL
$166.7 - $195.41 $91,851 - $107,670
-551 Reduced 8.72%
5,767 $1.06 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $267,144 - $301,130
1,477 Added 30.51%
6,318 $0
Q4 2018

Feb 08, 2019

SELL
$178.4 - $208.25 $29,614 - $34,569
-166 Reduced 3.32%
4,841 $942,000
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $99,130 - $111,756
535 Added 11.96%
5,007 $1.04 Million
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $36,364 - $40,845
219 Added 5.15%
4,472 $825,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $397,991 - $465,102
-2,349 Reduced 35.58%
4,253 $725,000
Q4 2017

Feb 07, 2018

BUY
$168.79 - $188.59 $19,410 - $21,687
115 Added 1.77%
6,602 $1.15 Million
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $334 - $382
-2 Reduced 0.03%
6,487 $1.21 Million
Q2 2017

Aug 15, 2017

BUY
N/A
6,489
6,489 $1.12 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wilbanks Smith & Thomas Asset Management LLC Portfolio

Follow Wilbanks Smith & Thomas Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.